| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000042596 |
| Receipt No. | R000048614 |
| Scientific Title | Investigation of the effects on 6-minute walking with a surgical mask in patients with chronic obstructive pulmonary disease |
| Date of disclosure of the study information | 2020/11/30 |
| Last modified on | 2021/04/17 (Ver. 3) |
| Basic information | ||
| Public title | Investigation of the effects on 6-minute walking with a surgical mask in patients with chronic obstructive pulmonary disease | |
| Acronym | Investigation of the Effects of Surgical Masks in Patients with COPD | |
| Scientific Title | Investigation of the effects on 6-minute walking with a surgical mask in patients with chronic obstructive pulmonary disease | |
| Scientific Title:Acronym | Investigation of the Effects of Surgical Masks in Patients with COPD | |
| Region |
|
|
| Condition | ||
| Condition | Chronic Obstructive Pulmonary Disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Examining the effects of wearing a surgical mask on patients with COPD |
| Basic objectives2 | Others |
| Basic objectives -Others | Effect of surgical mask on patients with COPD |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Differences in 6-minute walking distance between subjects with and without a surgical mask |
| Key secondary outcomes | Comparison of resting SPO2 values with and without a surgical mask
Comparison of lowest SPO2 values during exertion with and without a surgical mask Comparison of max HR values with and without a surgical mask Distance and time to achieve SPO2 < 90% with and without a surgical mask Comparison of the Borg Scale during 6-minute Walking with and without a Surgical Mask Clinical characteristics of patients with or without a 6-minute walk distance greater than Minimal Clinically Important Difference (MCID) with or without a surgical mask Clinical characteristics of patients with and without a surgical mask whose Borg scale was larger than or equal to MCID Clinical characteristics of patients with and without a surgical mask whose SPO2 fell below 90% |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | No treatment |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Patients who first wear a surgical mask for a 6-minute walk test and then do a 6-minute walk test without a surgical mask. | |
| Interventions/Control_2 | Patients who first undergo a 6-minute walk test without a surgical mask and then undergo a 6-minute walk test with a surgical mask. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | COPD patients aged 40 years or older attending Showa University Hospital | |||
| Key exclusion criteria | 1) Patients who have difficulty walking for 6 minutes due to neurological or orthopedic disorders
2) Patients who are contraindicated in the 6-minute walking test (Unstable angina within 1 month, myocardial infarction, stable angina, resting HR is 120/min or more, systolic blood pressure is 180mmHg or more, or diastolic blood pressure is 100mmHg or more) 3) Patients who have been diagnosed with heart failure and are being treated for heart failure 4) Patients who are judged to be ineligible at the discretion of the investigator |
|||
| Target sample size | 42 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Showa University | ||||||
| Division name | Department of Medicine, Division of Respiratory Medicine and Allergology | ||||||
| Zip code | 142-8666 | ||||||
| Address | 1-5-8 Hatanodai, Shinagawa-ku, Tokyo | ||||||
| TEL | 03-3784-8000 | ||||||
| hiraik@med.showa-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Showa University | ||||||
| Division name | Department of Medicine, Division of Respiratory Medicine and Allergology | ||||||
| Zip code | 142-8666 | ||||||
| Address | 1-5-8 Hatanodai, Shinagawa-ku, Tokyo | ||||||
| TEL | 03-3784-8000 | ||||||
| Homepage URL | |||||||
| hiraik@med.showa-u.ac.jp | |||||||
| Sponsor | |
| Institute | Showa University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Science and Technology Agency |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Showa University |
| Address | 1-5-8 Hatanodai, Shinagawa-ku, Tokyo |
| Tel | 03-3784-8129 |
| m-rinri@ofc.showa-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048614 |